# Loxo Oncology, Inc. — Form D

Loxo Oncology, Inc. of STAMFORD, CT, a company, filed a Form D exempt-offering notice with the SEC on 2014-05-12. The offering totals $23.9M, of which $23.9M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2014-05-12
- Form: D
- Accession: 0001581720-14-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $23.9M
- Amount sold: $23.9M
- Investors: 7
- Date of first sale: 2014-04-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-217142

## Issuer

- Name: Loxo Oncology, Inc.
- CIK: 0001581720
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 1 LANDMARK SQUARE, SUITE 1122, STAMFORD, CT, 06901
- Phone: 203-658-4749

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| James H Barrett | Director | Stamford, CT |
| Joshua H Bilenker | Director | Watertown, MA |
| David H Bonita | Director | Watertown, MA |
| Steven H Elms | Director | Watertown, MA |
| Keith H Flaherty | Director | Stamford, CT |
| Dov H Goldstein | Director | Stamford, CT |
| Avi H Naider | Director | Watertown, MA |
| Joshua H Bilenker | Executive Officer | Watertown, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2013-07-18](https://search.stillhousedata.com/formd/0001581720-13-000001) | D | — | $10.0M |

## More

- [CIK 1581720 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1581720&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001581720-14-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.